Jubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...

For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1175.90 crore, down 9.89 per cent from last...

The analyst suggested a stoploss at Rs 537 .

The analyst suggested a stoploss at Rs 533.

Motilal Oswal Securities is neutral Jubilant Life Sciences at a price target of Rs 905. The time period given to achieve the target is a qu...

Priyavrat Bhartia is the son of Chairman Shyam S Bhartia while Arjun Shanker Bhartia is the son of co-Chairman and Managing Director Hari S...

Shobhana Bhartia has barely time to catch her breath and chat over a cup of coffee with ET.

Hormusji N. Cama of Bombay Samachar Weekly, Mumbai has been elected the new president of INS (Indian Newspaper Society) for the year 2006-0...